DE BIASE, DARIO
 Distribuzione geografica
Continente #
AS - Asia 19.675
NA - Nord America 16.439
EU - Europa 11.830
SA - Sud America 1.061
AF - Africa 1.010
Continente sconosciuto - Info sul continente non disponibili 992
OC - Oceania 28
Totale 51.035
Nazione #
US - Stati Uniti d'America 16.018
VN - Vietnam 6.519
SG - Singapore 4.591
CN - Cina 4.347
IT - Italia 4.231
GB - Regno Unito 2.096
HK - Hong Kong 1.272
DE - Germania 1.225
SE - Svezia 940
BR - Brasile 787
FR - Francia 664
IN - India 664
KR - Corea 576
NL - Olanda 524
BD - Bangladesh 467
RU - Federazione Russa 461
IE - Irlanda 378
JP - Giappone 305
CI - Costa d'Avorio 290
FI - Finlandia 285
ZA - Sudafrica 266
CA - Canada 249
UA - Ucraina 164
SC - Seychelles 160
CH - Svizzera 147
TG - Togo 135
JO - Giordania 120
PH - Filippine 119
EE - Estonia 118
ID - Indonesia 118
AR - Argentina 103
BG - Bulgaria 103
AT - Austria 93
PK - Pakistan 88
PL - Polonia 83
TR - Turchia 77
MX - Messico 75
ES - Italia 69
IQ - Iraq 67
TH - Thailandia 67
TW - Taiwan 56
IR - Iran 47
EC - Ecuador 45
BE - Belgio 40
GR - Grecia 40
UZ - Uzbekistan 37
JM - Giamaica 29
NG - Nigeria 27
LT - Lituania 26
AU - Australia 25
CO - Colombia 25
CZ - Repubblica Ceca 25
PY - Paraguay 25
SA - Arabia Saudita 25
CL - Cile 24
DZ - Algeria 21
VE - Venezuela 21
RO - Romania 20
MY - Malesia 17
KE - Kenya 16
TN - Tunisia 16
AE - Emirati Arabi Uniti 14
EG - Egitto 14
MK - Macedonia 14
MA - Marocco 13
AZ - Azerbaigian 12
LB - Libano 12
PE - Perù 12
SN - Senegal 12
CR - Costa Rica 11
ET - Etiopia 10
HR - Croazia 10
KZ - Kazakistan 10
RS - Serbia 10
TT - Trinidad e Tobago 10
AL - Albania 9
NI - Nicaragua 9
DK - Danimarca 8
MD - Moldavia 8
NP - Nepal 8
OM - Oman 8
PT - Portogallo 8
GT - Guatemala 7
HN - Honduras 7
UY - Uruguay 7
DO - Repubblica Dominicana 6
NO - Norvegia 6
BO - Bolivia 5
GH - Ghana 5
SK - Slovacchia (Repubblica Slovacca) 5
CY - Cipro 4
KG - Kirghizistan 4
LV - Lettonia 4
MQ - Martinica 4
SI - Slovenia 4
UG - Uganda 4
CG - Congo 3
GE - Georgia 3
GY - Guiana 3
HU - Ungheria 3
Totale 49.974
Città #
Singapore 3.235
Ashburn 1.981
Southend 1.788
Ho Chi Minh City 1.723
Hanoi 1.448
Hong Kong 1.194
Hefei 1.171
Bologna 1.156
Fairfield 1.071
San Jose 934
Chandler 866
Santa Clara 703
Seoul 528
Houston 523
Council Bluffs 521
Seattle 518
Woodbridge 515
Beijing 479
Wilmington 476
Cambridge 415
Princeton 411
Los Angeles 404
Dallas 400
Dublin 373
Ann Arbor 365
Boardman 361
Dong Ket 299
Milan 299
Abidjan 290
New York 279
Lauterbourg 277
Tokyo 250
Da Nang 247
Helsinki 214
Haiphong 200
Berlin 146
Redmond 146
Nanjing 145
Westminster 145
Frankfurt am Main 139
Turin 137
Lomé 135
Buffalo 130
Rome 129
Padova 124
São Paulo 121
Amman 119
Bern 119
Rimini 117
Johannesburg 116
Redondo Beach 111
Bengaluru 109
Sofia 98
Jinan 92
Shanghai 91
Florence 87
Ha Long 87
Biên Hòa 85
Guangzhou 85
Hải Dương 85
Munich 79
Quận Bình Thạnh 78
Thái Nguyên 78
Chicago 76
San Diego 75
Can Tho 72
Saint Petersburg 71
Montreal 70
Jakarta 69
Ninh Bình 67
Falls Church 66
Phoenix 65
Shenyang 64
Changsha 62
Warsaw 61
Jacksonville 59
Atlanta 58
Denver 57
Hyderabad 57
Orem 57
Amsterdam 56
Vũng Tàu 56
London 54
Naples 54
Vienna 54
Bắc Ninh 53
Tianjin 52
Modena 50
Nanchang 50
Nuremberg 48
Toronto 48
Des Moines 45
Medford 44
Hebei 43
Brooklyn 42
San Francisco 42
Zhengzhou 42
Falkenstein 40
Lappeenranta 40
Bremen 39
Totale 31.105
Nome #
BRAF and MLH1 Analysis Algorithm for the Evaluation of Lynch Syndrome Risk in Colorectal Carcinoma Patients: Evidence-Based Data from the Analysis of 100 Consecutive Cases 642
Allele specific locked nucleic acid quantitative PCR (ASLNAqPCR): an accurate and cost-effective assay to diagnose and quantify KRAS and BRAF mutation. 600
MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis b-and c-related-hepatocellularcarcinoma 456
Different Methods in HPV Genotyping of Anogenital and Oropharyngeal Lesions: Comparison between VisionArray® Technology, Next Generation Sequencing, and Hybrid Capture Assay 440
La malattia di Gaucher: una sindrome da iperattivazione dell’Hippo pathway? 389
A commentary on interstitial pneumonitis induced by docetaxel: Clinical cases and systematic review of the literature 388
The role of next-generation sequencing in the cytologic diagnosis of pancreatic lesions 381
Spatial Cancer-Immune phenotypes predict shorter recurrence free survival in the NSMP molecular subtype of endometrial carcinoma 369
Molecular diagnostic of solid tumor using a next generation sequencing custom-designed multi-gene panel 348
Molecular biology of biliopancreatic lesions 342
Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance 341
Gene polymorphism in tissue epidermal growth factor receptor (EGFR) influences clinical and histological vulnerability of carotid plaques 320
Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma 317
Chalcones induce apoptosis, autophagy and reduce spreading in osteosarcoma 3D models 313
Mitochondrial DNA genotyping efficiently reveals clonality of synchronous endometrial and ovarian cancers 305
Epidermal Growth Factor Receptor (EGFR) Mutation in Exon 19 (p.E749Q) Confers Resistance to Gefitinib in One Patient With Lung Adenocarcinoma 302
BRAF exon 15 mutations in papillary carcinoma and adjacent thyroid parenchyma: A search for the early molecular events associated with tumor development 300
Correction to: Visani et al. mir-196b-5p and mir-200b-3p are differentially expressed in medulloblastomas of adults and children. diagnostics 2020, 10, 265 297
STK11 mutations correlate with poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemo-immunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 status 294
Can miRNAs be useful biomarkers in improving prognostic stratification in endometrial cancer patients? An update review 289
Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study 278
Multi-Gene Next-Generation Sequencing Panel for Analysis of BRCA1/BRCA2 and Homologous Recombination Repair Genes Alterations Metastatic Castration-Resistant Prostate Cancer 272
MicroRNA profiling reveals potential biomarkers for the early transformation of endometriosis towards endometriosis-correlated ovarian cancer 266
Homologous Recombination Deficiency (HRD) Status in Rare Histotypes of Ovarian Carcinomas: A Single-Center Experience 265
A novel T137A SOD1 mutation in an Italian family with two subjects affected by amyotrophic lateral sclerosis 265
MicroRNA and Metabolic Profiling of a Primary Ovarian Neuroendocrine Carcinoma Pulmonary-Type Reveals a High Degree of Similarity with Small Cell Lung Cancer 264
Analysis of MDM2 and TP53 genes in canine liposarcoma 260
Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I–III 260
BRAF V600E Status and Stimulated Thyroglobulin at Ablation Time Increase Prognostic Value of American Thyroid Association Classification Systems for Persistent Disease in Differentiated Thyroid Carcinoma 254
Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practice 253
Arid1a and ctnnb1/β-catenin molecular status affects the clinicopathologic features and prognosis of endometrial carcinoma: Implications for an improved surrogate molecular classification 248
Postsurgical Approaches in Low-Grade Oligodendroglioma: Is Chemotherapy Alone Still an Option? 247
Next-generation technologies in predictive molecular pathology of lung cancers 246
Does the site of origin of the microcarcinoma with respect to the thyroid surface matter? A multicenter pathologic and clinical study for risk stratification 241
What is new on ovarian carcinoma: Integrated morphologic and molecular analysis following the new 2020 world health organization classification of female genital tumors 241
High MYC levels favour multifocal carcinogenesis 239
Immunomagnetic enrichment coupled to PAX8/TP53 molecular pathology approach increases sensitivity in the detection of ovarian cancer cells in ascites 238
Classification systems of endometrial cancer: A comparative study about old and new 237
454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samples 235
HLA Class I Loss in Endometrial Carcinoma: Differences in the Immunosurveillance Pattern in Molecular Subtypes 234
Accuracy of World Health Organisation-grade parameters (necrosis and mitotic activity) and foci of vascular invasion in predicting prognosis of papillary thyroid carcinoma. A case–control validation study 234
T([20]) repeat in the 3'-untranslated region of the MT1X gene: a marker with high sensitivity and specificity to detect microsatellite instability in colorectal cancer 234
Papillary thyroid carcinoma tall cell variant shares accumulation of mitochondria, mitochondrial DNA mutations, and loss of oxidative phosphorylation complex I integrity with oncocytic tumors 234
Activity of the novel T137A SOD1 mutation in amyotrophic lateral sclerosis patients 231
Definition of miRNAs expression profile in glioblastoma samples: the relevance of non-neoplastic brain reference. 226
Evaluation of RNA from human trabecular bone and identification of stable reference genes 221
n-3 LC-PUFAs modulate global gene expression in the left ventricle of spontaneously hypertensive rats 221
Matricellular proteins and survival in patients with pancreatic cancer: A systematic review 217
Adenoid Cystic Carcinoma of the Breast Associated With Invasive Duct Carcinoma: A Case Report 215
Clinical relevance of gene mutations and rearrangements in advanced differentiated thyroid cancer 214
Perfusion-based ex vivo culture of frozen ovarian cancer tissues with preserved tumor microenvironment 214
Expanding the Spectrum of BRAF Non-V600E Mutations in Thyroid Nodules: Evidence-Based Data from a Tertiary Referral Centre 213
Human Cancer Cells Signal Their Competitive Fitness Through MYC Activity 213
RET mutation and increased angiogenesis in medullary thyroid carcinomas 213
Insights into the impact of chromosome 3p mutations in advanced renal cell carcinoma treated with immune-based combinations or targeted therapy: A single-center experience 212
Erratum to: Incidence of neuroepithelial primary brain tumors among adult population of Emilia-Romagna Region, Italy 210
Identification of miR-499a-5p as a Potential Novel Biomarker for Risk Stratification in Endometrial Cancer 209
BRAF V600E mutation in neocortical posterior temporal epileptogenic gangliogliomas 208
Abstract 2603: What's more in serrated lesions: interobserver agreement and molecular features 207
Cutaneous Melanoma with "Paradoxical" p16 Hyper-expression: Molecular and Immunohistochemical Analysis of an Exceedingly Rare Entity with a Focus on Regulator Molecules of the Cell Cycle 206
Oral sialadenoma papilliferum with kras mutation in a patient with linear nevus sebaceous syndrome 202
Molecular analysis driven video-assisted thoracic surgery resections in bilateral synchronous lung cancers: From the test tube to the operatory room 202
A neurogenic model of adult brain cancer in Drosophila 202
miRNA levels are associated with body mass index in endometrial cancer and may have implications for therapy 202
Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review 201
Large Population Of Homogeneous Spheroids Models For Testing Toxicity And Diffusion Of Nanomaterials 200
Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes 200
Relevance of ARID1A Mutations in Endometrial Carcinomas 200
Failure of the PTEN/aPKC/Lgl Axis Primes Formation of Adult Brain Tumours in Drosophila 199
Oncocytic carcinoma of the breast: frequency, morphology and follow-up 199
aPKCz cortical loading is associated with Lgl cytoplasmic release and tumor growth in Drosophila and human epithelia. 199
Co-administration of propionate or protocatechuic acid does not affect dha-specific transcriptional effects on lipid metabolism in cultured hepatic cells 199
Distinctive features of blood- and ascitic fluid-derived extracellular vesicles in ovarian cancer patients 198
Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma 197
Brachial amyotrophic diplegia associated with the a140a superoxide dismutase 1 mutation. 197
Computer-aided assessment of the extra-cellular matrix during pancreatic carcinogenesis: A pilot study 196
Ectopic Thyroid Tissue in the Adrenal Gland: Report of a Case. 195
Genomic profiling of mitochondrion-rich breast carcinoma: chromosomal changes may be relevant for mitochondria accumulation and tumour biology 195
The right drug for the right patient at the right time with the right test in differentiated thyroid cancer (DTC) 194
Oncocytic glioblastoma: a glioblastoma showing oncocytic changes and increased mitochondrial DNA copy number 194
The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female Power 194
Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study 193
Patient outcomes following second surgery for recurrent glioblastoma 193
High diagnostic adequacy and accuracy of the new 20G procore needle for EUS-guided tissue acquisition: Results of a large multicentre retrospective study 192
Immunomorphology and molecular biology of mixed primary liver cancers: is Nestin a marker of intermediate-cell carcinoma? 192
Non-canonical IDH1 and IDH2 mutations: a clonal and relevant event in an Italian cohort of gliomas classified according to the 2016 World Health Organization (WHO) criteria 190
Concordance between RTOG and EORTC prognostic criteria in low-grade gliomas 188
Metabolic pseudoprogression in a patient with metastatic KIT exon 11 GIST after 1 month of first-line imatinib: a case report 186
miRNAs expression analysis in paired fresh/frozen and dissected formalin fixed and paraffin embedded glioblastoma using real-time pCR. 186
The immunoproteasome β5i subunit is a key contributor to ictogenesis in a rat model of chronic epilepsy 185
Prevalence of Antigens/Antibodies Against Hepatitis B and C Viruses in A Cohort of Italian Patients with Pancreatic Adenocarcinoma Admitted to Two Hospital Wards in Italy: A Pivotal Retrospective Study 184
Linc00941 Is a Novel Transforming Growth Factor β Target That Primes Papillary Thyroid Cancer Metastatic Behavior by Regulating the Expression of Cadherin 6 183
A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors 181
Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysis 180
Importanza della modulazione dell’espressione genica nel meccanismo di protezione dei PUFA n-3 verso l’ipertrofia cardiaca 180
Team work and cytopathology molecular diagnosis of solid pancreatic lesions 180
Protein Expression, Amplification, and Mutation of HER2 Gene in Canine Primary Pulmonary Adenocarcinomas: Preliminary Results 179
Angiosarcoma and anaplastic carcinoma of the thyroid are two distinct entities: a morphologic, immunohistochemical, and genetic study 179
MiR-196B-5P and miR-200B-3P are differentially expressed in medulloblastomas of adults and children 179
Studio del pathway della necroptosi in modelli cellulari umani della malattia di Gaucher 178
Totale 24.501
Categoria #
all - tutte 138.150
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 138.150


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.477 0 133 177 234 362 262 112 310 215 232 887 553
2022/20234.730 412 560 247 525 300 387 144 284 892 204 393 382
2023/20241.874 182 257 115 183 185 273 118 134 104 105 95 123
2024/20257.699 425 906 644 523 946 396 547 256 153 618 678 1.607
2025/202623.356 3.686 2.448 1.838 1.635 1.691 973 2.688 682 3.700 1.586 1.509 920
2026/20271.274 689 585 0 0 0 0 0 0 0 0 0 0
Totale 51.035